{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:49:20Z","timestamp":1762876160642,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.arteri.2019.11.005","type":"journal-article","created":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T01:02:32Z","timestamp":1586566952000},"page":"101-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Las dislipidemias y su tratamiento en centros de alta complejidad en Colombia"],"prefix":"10.1016","volume":"32","author":[{"given":"\u00c1lvaro J.","family":"Ruiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hernando","family":"Vargas-Uricoechea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Urina-Triana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Rom\u00e1n-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Isaza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin","family":"Etayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adalberto","family":"Quintero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dora In\u00e9s","family":"Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Manuel","family":"Toro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo","family":"Parra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alonso","family":"Merch\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Cadena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hern\u00e1n","family":"Yupanqui Lozano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Mauricio","family":"C\u00e1rdenas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1lvaro Mauricio","family":"Quintero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo","family":"Botero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica","family":"Jaramillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Manuel","family":"Arteaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Vesga-Angarita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etna","family":"Valenzuela-Plata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica","family":"Betancur-Valencia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl.","key":"10.1016\/j.arteri.2019.11.005_bib0200","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacc.2012.11.002","article-title":"The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: a report from the American College of Cardiology","volume":"60","author":"Laslett","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.arteri.2019.11.005_bib0205","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1093\/eurheartj\/ehv428","article-title":"Cardiovascular disease in Europe--epidemiological update 2015","volume":"36","author":"Townsend","year":"2015","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2019.11.005_bib0210","first-page":"e38","article-title":"Heart disease and stroke statistics-2016 update: a report from the American Heart Association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation."},{"key":"10.1016\/j.arteri.2019.11.005_bib0215","unstructured":"PAHO\/WHO. Health in South America. Health Situation Policies and Systems Overview; 2012 [consultado 1 Sep 2018]. Disponible en: http:\/\/new.paho.org\/chi\/images\/PDFs\/health%20in%20sam%202012%20(jan.13).pdf"},{"journal-title":"Non-communicable diseases country profiles","year":"2014","key":"10.1016\/j.arteri.2019.11.005_bib0220"},{"journal-title":"Cardiovascular disease: Global Atlas on Cardiovascular Disease Prevention and Control","year":"2012","key":"10.1016\/j.arteri.2019.11.005_bib0225"},{"key":"10.1016\/j.arteri.2019.11.005_bib0230","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/j.jacc.2012.08.962","article-title":"Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke)","volume":"60","author":"Smith","year":"2012","journal-title":"J Am Coll Cardiol."},{"issue":"Suppl.","key":"10.1016\/j.arteri.2019.11.005_bib0235","doi-asserted-by":"crossref","first-page":"C7","DOI":"10.1016\/j.jacc.2005.09.068","article-title":"Pathogenesis of atherosclerosis","volume":"47","author":"Falk","year":"2006","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.arteri.2019.11.005_bib0240","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.beem.2013.10.001","article-title":"The metabolic and pharmacologic bases for treating atherogenic dyslipidaemia","volume":"28","author":"Chan","year":"2014","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"10.1016\/j.arteri.2019.11.005_bib0245","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s11745-010-3408-1","article-title":"Atherogenic dyslipidemia: cardiovascular risk and dietary intervention","volume":"45","author":"Musunuru","year":"2010","journal-title":"Lipids."},{"key":"10.1016\/j.arteri.2019.11.005_bib0250","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/01.CIR.82.2.495","article-title":"Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk","volume":"82","author":"Austin","year":"1990","journal-title":"Circulation."},{"key":"10.1016\/j.arteri.2019.11.005_bib0255","first-page":"CD004816","article-title":"Statins for the primary prevention of cardiovascular disease","author":"Taylor","year":"2013","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.arteri.2019.11.005_bib0260","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/j.jacc.2013.11.005","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Goff","year":"2014","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.arteri.2019.11.005_bib0265","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.atherosclerosis.2016.08.018","article-title":"2016 ESC\/EAS Guidelines for the management of dyslipidaemias","volume":"253","author":"Catapano","year":"2016","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.arteri.2019.11.005_bib0270","first-page":"635","article-title":"Diagnosis, prevention, and management of statin adverse effects and intolerance: proceedings of a Canadian Working Group Consensus Conference","volume":"27","author":"Mancini","year":"2011","journal-title":"Can J Cardiol."},{"key":"10.1016\/j.arteri.2019.11.005_bib0275","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.atherosclerosis.2009.09.014","article-title":"Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia: a large cross-sectional study in The Netherlands","volume":"209","author":"Pijlman","year":"2010","journal-title":"Atherosclerosis."},{"journal-title":"Encuesta Nacional de Salud","year":"2007","key":"10.1016\/j.arteri.2019.11.005_bib0280"},{"journal-title":"Enfermedad cardiovascular: principal causa de muerte en Colombia","year":"2013","key":"10.1016\/j.arteri.2019.11.005_bib0285"},{"key":"10.1016\/j.arteri.2019.11.005_bib0290","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/HJH.0b013e328332c353","article-title":"Hypertension in seven Latin American cities: the Cardiovascular Risk Factor Multiple Evaluation in Latin America (CARMELA) study","volume":"28","author":"Hern\u00e1ndez-Hern\u00e1ndez","year":"2010","journal-title":"J Hypertens."},{"key":"10.1016\/j.arteri.2019.11.005_bib0295","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation."},{"key":"10.1016\/j.arteri.2019.11.005_bib0300","first-page":"205","article-title":"[Cardiovascular risk factors prevalence among patients with dyslipidemia in Colombia]","volume":"30","author":"Machado-Alba","year":"2013","journal-title":"Rev Peru Med Exp Salud Publica."},{"key":"10.1016\/j.arteri.2019.11.005_bib0305","first-page":"30","article-title":"Prevalence of dyslipidemias in three regions in Venezuela: The VEMSOLS study results","volume":"110","author":"Gonz\u00e1lez-Rivas","year":"2018","journal-title":"Arq Bras Cardiol."},{"key":"10.1016\/j.arteri.2019.11.005_bib0310","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.recesp.2012.02.005","article-title":"Magnitude and management of hypercholesterolemia in the adult population of Spain, 2008-2010: The ENRICA study","volume":"65","author":"Guallar-Castill\u00f3n","year":"2012","journal-title":"Rev Esp Cardiol (Engl Ed)."},{"key":"10.1016\/j.arteri.2019.11.005_bib0315","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1007\/s12325-015-0252-y","article-title":"Prevalence, treatment, and control of hypercholesterolemia in high cardiovascular risk patients: evidences from a systematic literature review in Spain","volume":"32","author":"De la Sierra","year":"2015","journal-title":"Adv Ther."},{"key":"10.1016\/j.arteri.2019.11.005_bib0320","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.jacl.2017.05.008","article-title":"Identifying familial hypercholesterolemia in Colombia","volume":"11","author":"Toro","year":"2017","journal-title":"J Clin Lipidol."},{"issue":"Supl. 4","key":"10.1016\/j.arteri.2019.11.005_bib0325","first-page":"4","article-title":"Hipercolesterolemia familiar: art\u00edculo de revisi\u00f3n","volume":"23","author":"Merch\u00e1n","year":"2016","journal-title":"Rev Colomb Cardiol."},{"key":"10.1016\/j.arteri.2019.11.005_bib0330","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med."},{"key":"10.1016\/j.arteri.2019.11.005_bib0335","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med."},{"key":"10.1016\/j.arteri.2019.11.005_bib0340","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med."},{"key":"10.1016\/j.arteri.2019.11.005_bib0345","doi-asserted-by":"crossref","first-page":"479","DOI":"10.4158\/EP171764.GL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease - Executive summary","volume":"23","author":"Jellinger","year":"2017","journal-title":"Endocr Pract."},{"key":"10.1016\/j.arteri.2019.11.005_bib0350","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.arteri.2019.11.005_bib0355","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/eurheartj\/ehv043","article-title":"Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment Aetiology and Management","volume":"36","author":"Stroes","year":"2015","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2019.11.005_bib0360","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1177\/2047487318777079","article-title":"Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS)","volume":"25","author":"Danchin","year":"2018","journal-title":"Eur J Prev Cardiol."},{"key":"10.1016\/j.arteri.2019.11.005_bib0365","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijcard.2018.10.090","article-title":"The spectrum of the dyslipidemia in Colombia: The PURE study","volume":"284","author":"Camacho","year":"2019","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.arteri.2019.11.005_bib0370","first-page":"390","article-title":"[Risk factors for cardiovascular and chronic diseases in a coffee-growing population]","volume":"14","author":"Gonz\u00e1lez","year":"2012","journal-title":"Rev Salud Publica (Bogot\u00e1)."},{"key":"10.1016\/j.arteri.2019.11.005_bib0375","first-page":"433","article-title":"[Cardiovascular risk factors in an urban Colombia population]","volume":"13","author":"Pati\u00f1o-Villada","year":"2011","journal-title":"Rev Salud Publica (Bogot\u00e1)."},{"key":"10.1016\/j.arteri.2019.11.005_bib0380","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ypmed.2009.12.011","article-title":"Dyslipidemia in seven Latin American cities: CARMELA study","volume":"50","author":"Vinueza","year":"2010","journal-title":"Prev Med."},{"key":"10.1016\/j.arteri.2019.11.005_bib0385","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/01.hjr.0000219113.40662.dd","article-title":"Prevalence and impact of cardiovascular risk factors in Bucaramanga Colombia: results from the Countrywide Integrated Noncommunicable Disease Intervention Programme (CINDI\/CARMEN) baseline survey","volume":"13","author":"Bautista","year":"2006","journal-title":"Eur J Cardiovasc Prev Rehabil."},{"key":"10.1016\/j.arteri.2019.11.005_bib0390","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ijcard.2017.05.059","volume":"243","author":"Ponte-Negretti","year":"2017","journal-title":"Int J Cardiol."}],"container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916820300036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916820300036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:31:54Z","timestamp":1759325514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0214916820300036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0214916820300036"],"URL":"https:\/\/doi.org\/10.1016\/j.arteri.2019.11.005","relation":{},"ISSN":["0214-9168"],"issn-type":[{"type":"print","value":"0214-9168"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Las dislipidemias y su tratamiento en centros de alta complejidad en Colombia","name":"articletitle","label":"Article Title"},{"value":"Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arteri.2019.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Sociedad Espa\u00f1ola de Arteriosclerosis. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}